A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179–187.Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the morning dose (ie, 0-hr Figure 2) was not correct. The arithmetic mean (SD) apixaban trough concentration on Day 4 prior to the morn...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/509058d95a684d238d443f75c6a68bb8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:509058d95a684d238d443f75c6a68bb8
record_format	dspace
spelling	oai:doaj.org-article:509058d95a684d238d443f75c6a68bb82021-12-02T02:13:33ZA randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]1179-1438https://doaj.org/article/509058d95a684d238d443f75c6a68bb82018-06-01T00:00:00Zhttps://www.dovepress.com/corrigendum-a-randomized-direct-comparison-of-the-pharmacokinet-peer-reviewed-article-CPAAhttps://doaj.org/toc/1179-1438Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179–187.Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the morning dose (ie, 0-hr Figure 2) was not correct. The arithmetic mean (SD) apixaban trough concentration on Day 4 prior to the morning dose was 24.6 (6.1) ng/mL. Read the original article.Frost CSong YBarrett YCWang JPursley JBoyd RALaCreta FDove Medical PressarticleTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol Volume 10, Pp 71-72 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Therapeutics. Pharmacology RM1-950
spellingShingle	Therapeutics. Pharmacology RM1-950 Frost C Song Y Barrett YC Wang J Pursley J Boyd RA LaCreta F A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
description	Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179–187.Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the morning dose (ie, 0-hr Figure 2) was not correct. The arithmetic mean (SD) apixaban trough concentration on Day 4 prior to the morning dose was 24.6 (6.1) ng/mL. Read the original article.
format	article
author	Frost C Song Y Barrett YC Wang J Pursley J Boyd RA LaCreta F
author_facet	Frost C Song Y Barrett YC Wang J Pursley J Boyd RA LaCreta F
author_sort	Frost C
title	A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
title_short	A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
title_full	A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
title_fullStr	A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
title_full_unstemmed	A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
title_sort	randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [corrigendum]
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/509058d95a684d238d443f75c6a68bb8
work_keys_str_mv	AT frostc arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT songy arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT barrettyc arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT wangj arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT pursleyj arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT boydra arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT lacretaf arandomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT frostc randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT songy randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT barrettyc randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT wangj randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT pursleyj randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT boydra randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum AT lacretaf randomizeddirectcomparisonofthepharmacokineticsandpharmacodynamicsofapixabanandrivaroxabancorrigendum
_version_	1718402594081079296

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

Ejemplares similares